As a control, we included plasma samples from recovered U.S. COVID-19 patients (n = 10) that showed IgM and IgG reactivity against the SARS-CoV-2 receptor binding domain, but not against the three full-length PfMSP1 variants. Here, CD40LG is linked to COVID-19.